• Open-Platform DLP Enables Precise 96-Well Hydrogel Printing

  2026-08-05

  The reference paper introduces a low-cost, open-platform digital light printer (OP-DLP) capable of high-throughput, spatially controlled hydrogel synthesis and localized light-activation in 96-well formats. This system overcomes reproducibility and scalability challenges in biomaterials research, offering new flexibility for cell signaling and surface patterning studies.

• Innovations in In Vitro Evaluation of Chlorambucil Responses

  2026-08-05

  Schwartz’s dissertation redefines in vitro drug evaluation by distinguishing growth inhibition from cell death in cancer assays, revealing that most agents—including nitrogen mustard alkylating agents like chlorambucil—exert complex, temporally distinct effects on both proliferation and viability. These insights enable more precise assay design and interpretation for cancer research applications.

• Aprotinin (BPTI, SKU A2574): Robust Protease Inhibition for

  2026-08-04

  This scenario-driven guide empowers biomedical researchers and lab technicians to overcome common cell assay challenges by leveraging Aprotinin (Bovine Pancreatic Trypsin Inhibitor, BPTI; SKU A2574). Drawing on peer-reviewed studies and validated protocols, the article details how APExBIO’s Aprotinin ensures consistent serine protease inhibition, enhances assay reproducibility, and supports sensitive, safe laboratory workflows.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Research Pre

  2026-08-04

  Kanamycin Sulfate stands out as a high-purity, water-soluble antibiotic for robust cell selection, resistance studies, and microbiology workflows. This guide unpacks stepwise protocols, advanced use-cases, and troubleshooting strategies, leveraging new findings in anti-infection research.

• MK 0893: Structural Mechanisms and Translational Impact in G

  2026-08-03

  Explore the precise molecular mechanism and translational impact of MK 0893, a potent glucagon receptor antagonist, with in-depth analysis of its structural binding, selectivity, and implications for type 2 diabetes research. Gain practical insights for advanced assay design and preclinical modeling.

• Silybin A in Immunometabolic Research: Beyond Hepatoprotecti

  2026-08-03

  Explore how Silybin A, a principal component of Silymarin, is shaping advanced immunometabolic research through its effects on inflammation, autophagy, and metabolic enzyme modulation. This article delivers unique insights into experimental design and translational potential not covered by standard hepatoprotective content.

• Prostaglandin E2: Mechanistic Insights & Strategic Leverage

  2026-08-02

  This article provides translational researchers with a mechanistic and strategic overview of Prostaglandin E2 (PGE2), highlighting its receptor-specific signaling, multi-domain applications, and practical guidance for integrating PGE2 into innovative workflows such as pancreatic organoid modeling. The discussion bridges recent advances in organoid technology with actionable protocol recommendations and translational relevance, positioning APExBIO’s high-purity PGE2 as a cornerstone for next-generation inflammation research and regenerative medicine.

• MTT in Endothelial Angiogenesis: Mechanistic Insights for In

  2026-08-01

  Explore how MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) enables advanced assessment of endothelial cell angiogenesis and viability. This article uniquely bridges in vitro colorimetric assay mechanisms with recent discoveries in vascular biology, providing actionable guidance for translational research.

• Araucarene Diterpenes from Agathis dammara Promote β Cell Re

  2026-07-31

  This study isolates and characterizes 16 araucarene diterpenoids from Agathis dammara, including 11 new molecules, and demonstrates their hypoglycemic effects through enhanced pancreatic β cell regeneration and glucose uptake in zebrafish. These findings provide a mechanistic basis for exploring diterpenes in diabetes research and metabolic disease therapeutics.

• CTP Solution Enhances In Vitro Transcription for mRNA-LNP Th

  2026-07-31

  CTP Solution (100 mM) delivers unmatched nucleotide purity for high-yield, low-immunogenicity mRNA synthesis—essential for next-gen cancer therapeutics. Discover how this reagent streamlines workflows, powers robust in vitro transcription, and addresses pitfalls in RNA amplification for lipid nanoparticle delivery.

• XPO1 Inhibition Enhances Platinum Sensitivity in GCB-DLBCL C

  2026-07-30

  This study demonstrates that XPO1 inhibition, using agents such as Selinexor, can significantly improve the efficacy of platinum-based chemotherapy in germinal-center B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) models. The findings support the strategic combination of XPO1 inhibitors with platinum compounds to tackle chemoresistance in aggressive lymphoma subtypes.

• TPCA-1: Precision IKK-2 Inhibitor Workflows for Inflammation

  2026-07-30

  TPCA-1 enables researchers to dissect the NF-κB axis with extraordinary selectivity, supporting robust cytokine suppression and disease modeling. This guide delivers actionable protocols, troubleshooting insights, and cross-assay enhancements for inflammation and acute kidney injury workflows.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-07-29

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in peptide synthesis and bioconjugation workflows. It should be used exclusively in in vitro protocols, as there is no supporting data for in vivo or clinical applications.

• Eicosapentaenoic Acid (EPA): Beyond Lipids to Immune Modulat

  2026-07-29

  Explore the multidimensional role of Eicosapentaenoic Acid (EPA) omega-3 fatty acid in cardiovascular and immune research. This article uniquely bridges membrane biology, lipid-lowering efficacy, and immunomodulatory mechanisms, offering advanced protocol guidance for translational scientists.

• Necrostatin-1: Precision RIP1 Kinase Inhibition in Necroptos

  2026-07-28

  Necrostatin-1 enables precise, selective inhibition of RIP1 kinase, empowering researchers to dissect necroptosis and inflammation pathways in disease models. With data-driven protocols and troubleshooting tips, this guide accelerates translational discovery in acute injury and cell death research.

453 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page